BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16407520)

  • 1. Cost-effectiveness of ICDs.
    Anderson KP
    N Engl J Med; 2006 Jan; 354(2):205-7; author reply 205-7. PubMed ID: 16407520
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness of ICDs.
    Fauchier L; Babuty D
    N Engl J Med; 2006 Jan; 354(2):205-7; author reply 205-7. PubMed ID: 16411302
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of ICDs.
    Stevenson LW; Stevenson WG
    N Engl J Med; 2006 Jan; 354(2):205-7; author reply 205-7. PubMed ID: 16411295
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness in a flat world--can ICDs help the United States get rhythm?
    Goldman L
    N Engl J Med; 2005 Oct; 353(14):1513-5. PubMed ID: 16207856
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of implantable cardioverter-defibrillators.
    Sanders GD; Hlatky MA; Owens DK
    N Engl J Med; 2005 Oct; 353(14):1471-80. PubMed ID: 16207849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators.
    Hauser RG
    J Am Coll Cardiol; 2005 Jun; 45(12):2022-5. PubMed ID: 15963404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defibrillators in heart failure and quality of life.
    Matlock DD
    N Engl J Med; 2009 Jan; 360(2):187-8; author reply 189. PubMed ID: 19129534
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
    Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
    J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of implantable cardioverter defibrillators in patients >or=65 years of age.
    Sanders GD; Kong MH; Al-Khatib SM; Peterson ED
    Am Heart J; 2010 Jul; 160(1):122-31. PubMed ID: 20598982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of implantable cardioverter-defibrillators.
    Boriani G; Biffi M; Martignani C; Gallina M; Branzi A
    Eur Heart J; 2001 Jun; 22(12):990-6. PubMed ID: 11428834
    [No Abstract]   [Full Text] [Related]  

  • 11. The high cost of implantable defibrillators.
    Hlatky MA; Mark DB
    Eur Heart J; 2007 Feb; 28(4):388-91. PubMed ID: 17032689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare and cost-effectiveness analysis.
    Smolkin MT
    N Engl J Med; 2006 Jan; 354(2):207-9; author reply 207-9. PubMed ID: 16411303
    [No Abstract]   [Full Text] [Related]  

  • 13. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study.
    Filion KB; Xie X; van der Avoort CJ; Dendukuri N; Brophy JM
    Int J Technol Assess Health Care; 2009 Apr; 25(2):151-60. PubMed ID: 19331707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
    Yao G; Freemantle N; Calvert MJ; Bryan S; Daubert JC; Cleland JG
    Eur Heart J; 2007 Jan; 28(1):42-51. PubMed ID: 17110403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost of implantable defibrillators: perceptions and reality.
    Camm J; Klein H; Nisam S
    Eur Heart J; 2007 Feb; 28(4):392-7. PubMed ID: 16887857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should we afford implantable cardioverter defibrillator therapy?
    Camm AJ
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):59. PubMed ID: 16265354
    [No Abstract]   [Full Text] [Related]  

  • 17. Regression methods for cost-effectiveness analysis with censored data.
    Willan AR; Lin DY; Manca A
    Stat Med; 2005 Jan; 24(1):131-45. PubMed ID: 15515137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How should we cost ICD therapy?
    Fox DJ; Davidson NC; Fitzpatrick AP
    Int J Cardiol; 2007 May; 118(1):1-3. PubMed ID: 17258335
    [No Abstract]   [Full Text] [Related]  

  • 19. Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population.
    Cowie MR; Marshall D; Drummond M; Ferko N; Maschio M; Ekman M; de Roy L; Heidbuchel H; Verboven Y; Braunschweig F; Linde C; Boriani G
    Europace; 2009 Jun; 11(6):716-26. PubMed ID: 19359333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Mark DB; Nelson CL; Anstrom KJ; Al-Khatib SM; Tsiatis AA; Cowper PA; Clapp-Channing NE; Davidson-Ray L; Poole JE; Johnson G; Anderson J; Lee KL; Bardy GH;
    Circulation; 2006 Jul; 114(2):135-42. PubMed ID: 16818817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.